000 | 01369 a2200433 4500 | ||
---|---|---|---|
005 | 20250513114512.0 | ||
264 | 0 | _c19970623 | |
008 | 199706s 0 0 eng d | ||
022 | _a0300-8126 | ||
024 | 7 |
_a10.1007/BF02113591 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMontella, F | |
245 | 0 | 0 |
_aImproving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug users. _h[electronic resource] |
260 |
_bInfection _c |
||
300 |
_a117-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdiagnosis |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCandidiasis, Oral _xcomplications |
650 | 0 | 4 |
_aDermatitis, Seborrheic _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin A _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xvirology |
700 | 1 | _aPezzotti, P | |
700 | 1 | _aDi Sora, F | |
700 | 1 | _aRecchia, O | |
700 | 1 | _aLauria, F | |
700 | 1 | _aRezza, G | |
773 | 0 |
_tInfection _gvol. 25 _gno. 2 _gp. 117-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02113591 _zAvailable from publisher's website |
999 |
_c9089911 _d9089911 |